Abstract
Aims: Monitoring treated patients with thyroid cancer for recurrent or metastatic disease is currently based upon the serial measurement of circulating plasma thyroglobulin (Tg) concentrations. However, the clinical usefulness of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have